SCHEMBL25631406

SCHEMBL25631406

Bc1c(B)c(B)c(-c2cccc3c2oc2cccc(-c4ccc5c(-c6ccccc6)c6cc(Cl)ccc6c(-c6ccccc6)c5c4)c23)c(B)c1B

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.36
▸ CA1 P00915 3/20 0.35
▸ CA2 P00918 3/20 0.35
▸ AHR P35869 3/20 0.35
▸ ADORA3 P0DMS8 2/20 0.32
▸ TNKS O95271 1/20 0.32
▸ MAOA P21397 1/20 0.32
▸ GABRP O00591 1/20 0.32
▸ GABRD O14764 1/20 0.32
▸ GABRA1 P14867 1/20 0.32
▸ GABRB1 P18505 1/20 0.32
▸ GABRG2 P18507 1/20 0.32
▸ GABRB3 P28472 1/20 0.32
▸ GABRA5 P31644 1/20 0.32
▸ GABRA3 P34903 1/20 0.32
▸ GABRA2 P47869 1/20 0.32
▸ GABRB2 P47870 1/20 0.32
▸ GABRA4 P48169 1/20 0.32
▸ GABRE P78334 1/20 0.32
▸ GABRA6 Q16445 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25632246 0.93 ALOX5 (0.40) ALOX5CA1CA2AHRPIM1
SCHEMBL25631427 0.91 ALOX5 (0.39) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL25625093 0.90 ALOX5 (0.42) ALOX5CA1CA2AHRADORA3
SCHEMBL25632002 0.85 ALOX5 (0.36) ALOX5CA1CA2AHRSMN1; SMN2
SCHEMBL25625070 0.84 AHR (0.48) ALOX5CA1CA2AHRADORA3
SCHEMBL25625067 0.83 ALOX5 (0.53) ALOX5CA1CA2AHRADORA3
SCHEMBL25625100 0.83 ALOX5 (0.53) ALOX5CA1CA2AHRADORA3
SCHEMBL22503842 0.83 ALOX5 (0.36) ALOX5CA1CA2AHRPIM1
SCHEMBL25624543 0.83 ALOX5 (0.48) ALOX5AHRPIM1CSNK2A2CSNK2B
SCHEMBL25624509 0.81 ALOX5 (0.46) ALOX5PIM1CSNK2A2CSNK2BPIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183200-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD (KR) 2023-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183200-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME TRPA1, CRY2, SUN2 ALOX5 815/4885CA1 2991/4885CA2 2769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback